Intellectual Property India Publishes Patent Application for 'Large-Scale Flaviviral Vaccine Production And Manufacture' Filed by Takeda Vaccines, Inc.

MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517055462 A) filed by Takeda Vaccines, Inc., Cambridge, U.S.A., on June 9, for 'large-scale flaviviral vaccine production and manufacture.'

Inventor(s) include Santangelo, Joseph, David; Livengood, Jill, A; Lee, Yockann; and Luo, Weiwen.

The application for the patent was published on Aug. 22, under issue no. 34/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides methods for large-scale flaviviral vaccine production and manufacture. The methods provided herein are specifically contemplated for large-scale production and manufacture of live, attenuated flaviviral vaccines such as live, attenuated, dengue virus vaccines. Further, the methods provided herein pertain to formulation of live, attenuated, monovalent, divalent, trivalent, or tetravalent viral vaccine products."

The patent application was internationally filed on Nov. 29, 2023, under International application No.PCT/US2023/081551.

Disclaimer: Curated by HT Syndication.